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Abstract 
Purpose: The purpose of this evidenced-based education project was (i) assess current barriers 
and determining factors associated with medication adherence and how this coincides with health 
outcomes, (ii) assess whether medication adherence and hospital re-admission rates were 
improved with a comprehensive medication discharge educational plan.   
Setting: The project took place on a 35 bed post interventional care unit (4IC) located in a  
433 bed community care hospital in Central Kentucky. 
Population: The population for this study was a sample of 10 acute myocardial infarction 
patients post percutaneous coronary intervention. Thirty percent of participants were female and 
60% were male. Mean age was 63.6 years old (SD=10.5). 
Inclusion Criteria: English speaking subjects who were post percutaneous coronary 
intervention and discharged on anti-platelet medication. Access to a phone for the 7 day post 
discharge phone call was a requirement for study participation.  
Design and Methods: Data analysis was performed using SPSS® version 23.0 (SPSS Inc., 
Chicago, IL). Pre and post tests were scored and statistically analyzed to assess mean scores 
prior to, and following educational intervention. Data were analyzed using descriptive statistics. 
Paired T-tests were conducted to compare the differences in mean scores. This study considered 
values of p < 0.0001 significant for the analysis. Enrolled patients were seen on the morning of 
hospital discharge and the following activities occurred: A medication chart was given to 
patients that included anti-platelet medication name, dosage, indication, and frequency. The 
teach-back method was employed to assess patient understanding and retention. One week post-
discharge patients were phoned to confirm discharge medications were filled as well as  
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assessment of understanding and timing of anti-platelet medications via the teach-back method. 
Patients were reminded of their 30 day clinic appointment and the importance of attending this 
visit. Patients were seen at their 30 day standard of care clinic visit to assess adherence at 30 
days.  
Results and Conclusion: Participation in this project ultimately yielded a significant increase in 
anti-platelet medication knowledge from pre-test to post test. Baseline mean pre-test score of 
1.30 (SD=.483); participants’ mean score significantly increased to 3.00 (SD=.000). There was 
no significant difference between 7 day and 30 day adherence rates and knowledge. Seven day 
mean pre-test score of 2.90 (.316) and mean post test score of 3.00 (SD=.000). 100% of study 
subjects were taking anti-platelet medications at 7 days and 90% of subjects were taking 
medications at 30 days. One study subject was seen in the emergency room within 30 days of 
index procedure with reports of shortness of breath and angina. A full cardiac workup concluded 
that the stent was patent and anti-platelet medication was changed. It was thought by the 
overseeing cardiology service that this subject was a poor responder to current therapy. It is 
unknown if this subject was adherent at 30 days because she did not attend the 30 day clinic 
visit.    
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                                                        Background 
Definition 
Medication adherence has been defined as the active, voluntary, and collaborative 
involvement of the patient in a mutually acceptable course of behavior to produce a therapeutic 
result (Ho, Bryson, & Rumsfeld, 2009).  
Associated Costs 
Medication adherence continues to be a growing concern to healthcare providers and 
other stakeholders because the relationship between compliance and adverse outcomes has been 
linked to higher costs of care. The total cost estimates as a result of medication non-adherence 
range from $100 billion to $300 billion annually (Bosworth et al., 2011). The American College 
of Preventative Medicine (2011) estimates that non-adherence costs average $2,000 per patient 
in physician visits annually. More than forty percent of nursing home admissions are a direct 
result of non-adherence and this rate is expected to rise as the number of chronic diseases 
increase (Lau & Nau, 2009). It is estimated that for every dollar spent on adhering to a 
prescribed medication, medical costs would be reduced by $9.08 (Bosworth et al., 2011).  
Morbidity and Mortality 
Approximately 125,000 deaths per year in the United States are due to medication non-
compliance, and between 33% and 69% of medication related admissions in the United States 
are to due to poor adherence (Bosworth et al., 2011). While medications are effective in 
combating disease, their full benefits are not often realized because approximately 20%-50% of 
patients do not take their medications as prescribed (Brown & Bussell, 2011). Patients who filled  
 
 
                                                                3 
  
 
none of their discharge medications within 120 days after an acute myocardial infarction (AMI) 
had an 80% increase in chance of death; those who filled some of their medications had a 44% 
increase in chance of death (Jackevicius, Li, & Tu, 2008). Non-adherence can be attributed to 
30%-50% of treatment failures and non-adherence leads to worsen outcomes such as increased, 
preventable hospitalization rates, and increased healthcare costs (Sokol, McGuigan, Verbrugge, 
& Epstein, 2005).  
Guidelines 
Currently, measurement of patient adherence to medication regimes and the incorporation 
of interventions to improve adherence are rarely used in clinical practice. Medication adherence 
has been termed the “next frontier in quality improvement” and is an important clinical issue that 
needs addressed (Ho, Bryson, & Rumsfeld, 2009). Given the magnitude and importance of poor 
medication compliance and programs to aid in this, the World Health Organization has 
developed evidence-based guidelines for clinicians, health care managers, and policymakers to 
assist in strategies to improve medication compliance (Osterberg & Blaschke, 2005). 
Medications are imperative in treatment and disease prevention. It has been reported that 
medication use in the United States has risen from approximately 4 drugs prescribed per person 
from 1995 to 1996 to 5.2 drugs from 2001 to 2002 (Tarn et al., 2006). Medication non-adherence 
may occur at various levels in the patient’s decision-making process. It may occur at the start of 
therapy if a patient receives the initial prescription and fails to fill it, or it may occur after 
initiation of therapy and the patient fails to comply with instructions or fails to refill the 
prescription (Jackevicius, Li, & Tu, 2008). The misuse of medications can result in disease 
progression, drug overdose, hospitalizations, and increased healthcare costs. Reasons for overall  
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medication non-adherence are reflected in barriers to medication adherence, condition related 
factors, socio-economic factors, and communication (Wroth & Pathman, 2006). With the number 
of medication use on the rise, it is critical that patients are instructed on the proper use of 
prescribed medication regimens. Haskard & DiMattreoo (2009) attribute communication 
between healthcare providers and patients regarding medication regimes as significant in 
predicting adherence among patients. Adherence requires the patient to believe there is a benefit 
to the medication prescribed and agree with the instructions on how to take it. This can be 
particularly challenging in the cardiovascular population due to the fact that patients may not see 
immediate symptom improvement.   
Teach-Back Method 
With the increase in the incidence of chronic disease, patient self-management has 
become increasingly important. For patients to effectively manage their health conditions they 
must effectively understand their disease process, rationales for treatments, medication regimes, 
and associated side effects.  Jack et al. (2009) found that patients’ understanding of medication at 
hospital discharge was approximately 15%, and of those 15%, they were unaware that a new 
medication had been prescribed. Additionally, only half reported sufficient understanding of 
specific information related to medications, including dosage, dosage schedule, and purpose.   
 Assessing patients comprehension and recall ability helps predict their adherence to 
medical management. For effective teaching and assessment of patient comprehension and 
recall, a patient-centered approached must be utilized. The teach-back method confirms patient 
understanding and can assist in closing the communication gap between the clinician and patient 
while enhancing patient knowledge (Ping, 2012).  
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Description of the Practice Inquiry Project 
This practice inquiry project implemented an evidenced based, nurse-driven, 
multidisciplinary medication discharge process in AMI patients discharged on anti-platelet 
medications post percutaneous coronary intervention at a 433 bed community care hospital 
located in Central Kentucky. The project took place on a 35 bed post interventional care unit 
(4IC). A Pre/Post- test analysis was used at 3 time points to determine the educational impact on 
patient knowledge and adherence to prescribed anti-platelet medication. 
                                                Goals and Objectives 
The objectives of this project were to: (i) assess current barriers and determining factors 
associated with medication adherence and how this coincides with health outcomes, (ii) assess 
whether medication adherence and hospital re-admission rates were improved with a 
comprehensive medication discharge educational plan.   
                                                          Methods 
Approval Process 
 Following project proposal development and committee approval, clearance was 
obtained from the Research Oversight Office at Kentucky One Health. An expedited proposal 
was approved by the University of Kentucky Institutional Review Board (IRB). The Chief 
Nursing Officer, physicians, advanced practice providers, and the 4IC nursing manger and unit 
staff were informed of the project via email and in person communication. Approval was 
obtained from the manager of the Post Interventional Care Unit Manager. 
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Study Setting: 
 The project took place on a 35 bed post interventional care unit (4IC) located in a  
433 bed community care hospital in Central Kentucky. The hospital is accredited by The Joint 
Commission for Accreditation of Hospitals. The hospital is also a designated Society of 
Cardiovascular Chest Pain center.      
Study Population 
The target population for this study was English speaking cardiology patients who 
underwent percutaneous coronary intervention and were discharged on anti-platelet therapy. 
Eligibility in this study required access to either a land line or cell phone. A total of 12 subjects 
were approached for a total of 10 participants.    
Procedures 
 A formal in-service was held with the unit staff and manager providing them with the 
details of the project and how this would complement their current practices. Enrolled patients 
were identified by screening the daily cath lab schedule. Eligible patients were approached for 
consent into this study, and after informed consent, seen prior to hospital discharge. No standard 
practices was interrupted by this project; medication reconciliation and all discharge procedures 
conducted by the discharge nurse took place, including assessment of financial barriers 
associated with medications. As part of this project, a medication chart was given to patients that 
included anti-platelet medication name, dosage, indication, and frequency (Appendix A). The 
teach-back method was employed by the study PI to assess patient understanding and retention. 
One week post-discharge patients were phoned by the study PI to confirm discharge medications 
were filled as well as assessment of understanding and timing of anti-platelet medications.  
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Patient understanding was confirmed via the teach-back method (Appendix B). Additionally, 
patients were reminded of their 30 day clinic appointment and the importance of attending this 
visit. Lastly, patients were seen at their 30 day standard of care clinic visit. At this visit 
medication adherence was assessed as well as any hospital re-admissions since their index 
procedure.  
Data Analysis: 
 Data analysis was performed using SPSS® version 23.0 (SPSS Inc., Chicago, IL). Pre 
and post tests were scored and statistically analyzed to assess mean scores prior to, and following 
educational intervention. Data were analyzed using descriptive statistics. Paired T-tests were 
conducted to compare the differences in mean scores. This study considered values of p < 0.0001 
significant for the analysis.  
Results 
Sample Characteristics 
 A total of 12 subjects were approached who met the inclusion criteria for the study, and 
10 subjects voluntarily participated in the study. Thirty percent of participants were Caucasian 
females and 70% were Caucasian males. Mean age was 63.6 years old (SD=10.5). All but 1 
study subject completed all required visits for a completion rate of 90%. Reason provided by the 
2 subjects who declined participation was access to a reliable phone and time commitment 
requirement.  
Study Results 
Participation in this project ultimately yielded a significant increase in anti-platelet 
medication knowledge from pre-test to post test. Baseline mean pre-test score of 1.30 (SD=.483);  
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participants’ mean score significantly increased to 3.00 (SD=.000). There was no significant 
difference between 7 day and 30 day adherence rates and knowledge. Seven day mean pre-test 
score of 2.90 (.316) and mean post test score of 3.00 (SD=.000) (Figure 1). One hundred percent 
of study subjects were taking anti-platelet medications at 7 days and 90% of subjects were taking 
medications at 30 days.  
One study subject was seen in the emergency room within 30 days of index procedure 
with complaints of shortness of breath and angina. A full cardiac workup concluded that the stent 
was patent and anti-platelet medication was changed. It was thought by the overseeing 
cardiology service that this subject was a poor responder to current therapy. It is unknown if this 
subject was adherent at 30 days because she did not attend the 30 day clinic visit.    
                                                       Discussion 
Guidelines from the American College of Cardiology, American College of Preventive 
Medicine, and the World Health Organization recommend clinicians implement strategies to 
improve medication adherence. Physicians and Advanced Practice Providers play an integral role 
in this process. Numerous studies have demonstrated a correlation between provider trust and 
adherence. A meta-analysis performed by Haskard and DiMatteo (2009) on provider 
communication and patient adherence found there was a 19% higher risk of non-adherence 
among patients whose provider communicates poorly compared to those providers who 
communicate well. Statically, the odds of patient adherence are 2.26 times higher if the provider 
communicates well. This translates into more than 183 million avoidable medical visits when 
strong provider/patient communication is present (Haskard and DiMatteo, 2009). Time has also 
been identified as a barrier in provider/patient communication. Studies have shown that some  
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patients are interrupted by their provider after an average of 22 seconds. It has also been 
demonstrated that when patients are allowed to speak freely, the average patient would speak 
initially for less than 2 minutes (McDonald, Gary, & Haynes, 2009). By opening the lines of 
communication this will allow for the acceptance of new medication, adherence to medication 
regimes, which will ultimately lead to improvement in health outcomes (American College of 
Preventative Medicine, 2011).  
Follow-up appointments after hospitalizations may also be a predictor of medication 
adherence. A study that included 20,976 patients looked at the effect of follow-up appointments 
in patients who were post AMI. Researchers found that at three months post AMI, one in three 
patients were no longer adherent to medications, including anti-platelet medications. It was also 
indentified that patients who had their first follow-up appointment within 4-6 weeks post 
discharge had significantly better adherence rates at both 90 days and one year compared with 
those who followed-up later or did not follow-up at all (Faridi et al., 2016).  
Brown and Bussell (2011) assert that while the provider has an integral role in this 
process, the patient must take an active role as well. It has been reported that a typical patient 
recalls as little as 50% of what is discussed at a medical encounter. Effective patient education 
must be multi-factorial, individualized, and delivered in a variety of ways outside the four walls 
of a hospital (Brown & Bussell, 2011). A key component of an adherence improving plan must 
be education. The more empowered the patient feels, the more likely they are to be motivated to 
manage their disease and adhere to treatment guidelines. Additional measures to ensure 
adherence is to actively involve the patient whenever possible in treatment decisions. By actively 
involving patients and offering choices, this will encourage active participation in their  
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healthcare and hopefully facilitate adherence to medication regimes (Garner, 2010).  
Using the teach-back approach is another method of confirming understanding and 
actively engaging the patient. During the teach-back process, the patient makes the transition 
from having their disease managed by the provider to managing it themselves. When teach-back 
is used, providers reinforce what the patient already knows and teach them what they do not. By 
repeating this process as part of the interactive communication loop, this increases patients’ self-
care capacity abilities (Maniaci, Heckman & Dawson, 2008).    
This practice inquiry project was designed to improve knowledge surrounding anti-
platelet medication in the post AMI/PCI patient population.  The results showed a statistically 
significant difference in patient knowledge and understanding from baseline pre/post test 
evaluation and continued retention through 30 days. Additionally, pre test data revealed that post 
AMI/PCI patients are not adequately being educated on anti-platelet medication use prior to 
hospital discharge.  
Implications for Practice 
Medication adherence has a tremendous impact on the healthcare system due to increased 
risks of mortality and hospital readmissions; it is not solely a patient problem. The results of this 
practice inquiry project suggest that improving patient knowledge surrounding medication 
regimes and encouraging self-management techniques could influence the patient’s decision 
making process, and with further research, implement evidenced based strategies targeted at 
adherence interventions. This is supported by recommendations from the American College of 
Cardiology, American College of Preventive Medicine, and the World Health Organization. 
Moreover, further research is needed to explore the impact of the discharge nurse in developing a  
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standardized discharge process and the role this plays in medication adherence. By implementing 
these types of practices throughout an institution, we can ensure that patients are equipment with 
the necessary tools to be an active participant in their healthcare.  
                                      Implications for Future Inquiry 
Future studies need to include a larger sample size and a more diverse patient population. 
Additional considerations may include a different study design or the addition of a control group 
to validate the hypothesis and a follow-up period of 1 year. The teach-back method has been 
demonstrated as an effective approach in increasing adherence, but there is little research with 
using this method in the AMI/PCI patient population. This small study utilized this method and 
was found to be successful in the 10 patients enrolled, but a larger sample is needed to validate 
this. Research has demonstrated that patients who had their first follow-up appointment within 4-
6 weeks following discharge have significantly better adherence rates at 90 days and one year 
compared with those who were lost to follow-up. Measures to ensure follow-up appointments are 
made prior to discharge and then reminders sent to patients prior to scheduled appointments 
should be standard practice. Lastly, findings should be published in medical journals to help 
guide future practice and research.  
                                                       Limitations 
Due to a small study sample (n=10), a larger study sample is needed to adequately 
demonstrate effectiveness and advocate the need for practice change. The sample is also 
comprised of all Caucasians, so this may not be a true representation of the population as a 
whole, nor generalizable to a diverse set of patients. Follow-up beyond 30 days was not feasible  
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in this study due to time constraints; however future research should be targeted to include a 
 larger sample size and follow-up through 1 year to gain a better understanding of contributing 
factors associated with medication adherence in the AMI/PCI patient population.  
                                                       Conclusion 
With the rising incidence of chronic disease, patient self-management is becoming 
increasingly important. An easy and cost effective way to assist with this is incorporating the 
teach-back method into practice. Using this technique can improve patient knowledge, outcomes, 
and self-management skills. Based on the findings from this study, evidence-based education in 
the form of the teach-back method was successful in improving medication adherence rates in 
the AMI/PCI patient population 30 days post index procedure. Due to limitations in this study, 
researchers were unable to demonstrate long-term effects of teach- back method in regards to 
medication adherence. However, a significant increase in baseline knowledge of medications 
made the patients feel as if they were taking an active part in their healthcare management, 
therefore, equipped with the necessary knowledge to make informed decisions. This is promising 
and warrants further investigation. Given the lack of research on this subject in the AMI/PCI 
patient population, further research is recommended to expand on this educational intervention in 
order to design, implement and evaluate programs that are effective and sustainable over time.  
As stated by Benjamin Franklin, “Tell me and I forget. Teach me and I remember. Involve me 
and I learn.” 
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Table 1: Strategies and No-Cost Resources 
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Figure 1: Difference in mean knowledge scores (N=10) 
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Appendix B: Medication Chart 
 Medication Chart for XXXXXXXX 
 
Name of 
Medication 
Dosage Frequency  
(how often) 
Indication  
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Appendix C: Phone Script  
One Week Phone Call Script and Data Collection Sheet 
 
Hello, may I speak with Ms./Mr. X,  
 
My name is Rebecca Thomas and I am a graduate student at the University of Kentucky. We met during 
your recent hospitalization at Saint Joseph Hospital. To refresh your memory, prior to discharge from 
the hospital we discussed your medications and you gave me permission to phone you, do you 
remember that? If so, do you still agree to be a part of this program?  
If patient agrees proceed with the following.  
I was wondering if you have a few minutes for me to go over your medications using the list we 
reviewed while you were in the hospital, do you have that? Also, can you bring all your medications to 
the phone, please? We will review them during this call. I will hold while you collect all of your 
medications, there is no need to hurry.  
Caller (PI): Do you have all of your medications and the list in front of you now?  
Caller (PI): I’m going to ask you a few questions about each one of your medications to see if there is 
anything I can help you with. We will go through your medications one by one.   
First of all, I want to make sure you were able to obtain all of the medications you were discharged 
home with, did you do this? If not, why?  
Next we will discuss how often you take each medication, any problems you have had and any questions 
you might have about them.  
Let’s start with the first medication on the list.  
- What is the name of the medication? If the patient is using a generic, make sure they understand 
that the brand and generic names are two names for the same medication.  
- What is the dosage of this medication?  
- How much do you take each time?  
- What do you take this medicine for?  
- Do you have any problems or concerns with this medicine?  
- Do you think you are experiencing any side effects with this medication?  
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If the patient has been prescribed any medication that the patient hasn’t mentioned, ask whether or 
not they are taking that medication.  
18 
If the patient is not taking the medication, ask why not. 
Caller (PI): Have you been using the medication chart that was provided to you prior to discharge?  
If yes, provide positive reinforcement of this tool. 
If no, suggest using this tool to help remember to take medicines as directed.  
Caller (PI): What questions do you have today regarding your medicines and/or medication chart?  
Appointment Reminder 
Caller (PI): I want to make sure you remember to come to your appointment with Dr. X on X. You were 
given an appointment with your doctor when you left the hospital. Can you please tell me: 
- When is your appointment? 
- Where is your appointment? 
- Are you able to make this appointment? If the patient can’t make the appointment, instruct to 
reschedule as close to the date of the originally scheduled appointment and stress the 
importance of attending this visit. Make sure the patient has the clinic phone number on hand.  
Caller (PI):  Please remember to bring your medication chart to your scheduled appointment on XX.  
Caller (PI): In addition to this call you will also receive a call from Dr. X’s clinic two days prior to your 
appointment to remind you of the date. At that time if you are unable to attend that appointment 
please make sure you reschedule this visit.  
Caller (PI): Do you have any questions at this time?  
Caller (PI): Thank you for your time, good bye. I look forward to seeing you on xxxxx.  
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